Baseline Characteristics

Demography and Medical history

	Telmisartan (n=120)	Enalapril (n=130)
Demography
Males, n (%)	87 (73)	95 (73)
Caucasians, n (%)	118 (98)	128 (98)
Age (years), mean ± SD	61.2 ± 8.5	60.0 ± 9.1
Body weight (kg), mean ± SD	90.6 ± 14.9	90.6 ± 17.4
BMI (kg/m²), mean ± SD	30.8 ± 4.4	30.6 ± 5.1
Medical History
GFR (ml/min/1.73m2), mean ± SD	91.4 ± 21.5	94.3 ± 22.1
UAER (µg/min), median	46.2	60.0
Microalbuminuria, n (%)	98 (82)	106 (82)
Macroalbuminuria, n (%)	22 (18)	23 (18)
History of CVD, n (%)	59 (49)	62 (49)

*All patients who were enrolled and received at least one dose of study medication

BMI, Body mass index

GFR, Glomerular filtration rate

UAER, Urinary albumin excretion rate

CVD, Cardiovascular disease

Baseline characteristics were generally similar between the treatment groups